Composition of the Nomination Committee of Orion Corporation

Composition of the Nomination Committee of Orion Corporation

ID: 493354

(Thomson Reuters ONE) -




ORION CORPORATION      STOCK EXCHANGE RELEASE 7 SEPTEMBER 2016 at 6.30 p.m.
EEST


Composition of the Nomination Committee of Orion Corporation


The Board of Directors of Orion Corporation has elected the following persons to
the Nomination Committee of the company:

* Kari Jussi Aho
* Erkki Etola
* Matti Kavetvuo
* Timo Maasilta
* Timo Ritakallio
* Seppo Salonen
* Hannu Syrjänen

Matti Kavetvuo was elected Chairman of the Committee.


The Committee prepares and presents a recommendation to the Board of Directors
for the proposal to the Annual General Meeting concerning the composition of the
Board.


The essentials of the working order of the Nomination Committee and a
description of the election process of its members are provided at
http://www.orion.fi/en/Orion-group/corporate-governance/board-of-
directors/board-committees/, a page in the Corporate Governance section of the
Orion Group internet website.



Orion Corporation



Timo Lappalainen   Olli Huotari
President and CEO SVP, Corporate Functions



Contact person:
Timo Lappalainen, President and CEO
tel. +358 10 426 3692

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02101 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. The core therapy areas of Orion's pharmaceutical R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion




developes inhaled Easyhaler® pulmonary drugs.

Orion's net sales in 2015 amounted to EUR 1,016 million and the company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Orion Oyj via GlobeNewswire




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Curetis Acquires Patents and Rights to Genetic Antibiotic Resistance and Susceptibility (GEAR) Database and Know-How from Siemens Starbreeze AB : 505 Games and Starbreeze Are Blowing the Vault Open with 'The Big Score' for PAYDAY 2: Crimewave Edition
Bereitgestellt von Benutzer: hugin
Datum: 07.09.2016 - 17:30 Uhr
Sprache: Deutsch
News-ID 493354
Anzahl Zeichen: 2703

contact information:
Town:

Espoo



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 231 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Composition of the Nomination Committee of Orion Corporation"
steht unter der journalistisch-redaktionellen Verantwortung von

Orion Oyj (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Orion Oyj



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z